RSIT(SH:688215)2022-04-25 16:00Financial Performance - The company's operating revenue for Q1 2022 was ¥46,197,644.21, representing a year-on-year increase of 75.67%[4] - The net profit attributable to shareholders decreased by 37.91% to ¥1,775,220.91[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses fell by 72.37% to ¥717,443.42[4] - Basic and diluted earnings per share decreased by 42.86% to ¥0.04[4] - In Q1 2022, the company's net profit was CNY 1,315,359.06, a decrease of 56.2% compared to CNY 3,002,800.51 in Q1 2021[18] - Operating revenue for Q1 2022 was CNY 50,253,761.89, an increase of 17.5% from CNY 42,894,332.47 in Q1 2021[20] - The company's operating profit for Q1 2022 was CNY 1,679,199.42, down 51.4% from CNY 3,458,071.12 in the same period last year[18] - Total comprehensive income for Q1 2022 was CNY 1,315,359.06, down 56.2% from CNY 3,002,800.51 in Q1 2021[18] Cash Flow and Liquidity - The net cash flow from operating activities was negative at -¥27,537,273.09, reflecting an increase in cash outflows due to inventory buildup[4][8] - The net cash flow from operating activities in Q1 2022 was negative at CNY -27,537,273.09, compared to a positive CNY 2,086,080.93 in Q1 2021[21] - The company reported cash and cash equivalents of CNY 69,149,594.45 at the end of Q1 2022, a decrease from CNY 110,140,380.55 at the end of Q1 2021[22] - Cash and cash equivalents as of March 31, 2022, were RMB 74,547,994.97, compared to RMB 60,112,558.95 at the end of 2021, reflecting a growth of approximately 24%[13] Research and Development - The total R&D investment amounted to ¥4,823,457.46, accounting for 10.44% of operating revenue, a decrease of 4.21 percentage points[5] - Research and development expenses increased to CNY 4,823,457.46 in Q1 2022, up 25.2% from CNY 3,851,572.39 in Q1 2021[18] - The company is focusing on expanding its market presence and enhancing its product offerings through ongoing research and development initiatives[12] Assets and Liabilities - The total assets at the end of the reporting period were ¥591,307,983.53, a decrease of 1.31% from the previous year[5] - Total assets as of March 31, 2022, were RMB 591,307,983.53, a slight decrease from RMB 599,154,225.74 at the end of 2021[14] - Total liabilities as of March 31, 2022, were RMB 147,074,809.63, down from RMB 156,236,410.91 at the end of 2021, indicating a reduction of about 5.4%[15] - Shareholders' equity as of March 31, 2022, was RMB 444,233,173.90, compared to RMB 442,917,814.83 at the end of 2021, reflecting a marginal increase of approximately 0.3%[15] Operational Challenges - The company expects continued challenges from rising raw material prices impacting profit margins while focusing on business expansion[8] - The company reported a net loss for Q1 2022, with total expenses exceeding total revenue, leading to a negative operating margin[16] Order Backlog - The company had an order backlog of ¥203 million as of the end of Q1 2022, indicating strong future revenue potential[8]